Governments seek buyer to save Quebec-based vaccine maker
The Quebec government says it's looking to find a buyer for Medicago Inc., the Quebec-based COVID -19 vaccine manufacturer that will be shut down by parent company Mitsubishi Chemical.
Quebec Economy Minister Pierre Fitzgibbon said Friday the province has had preliminary talks with potential buyers in the pharmaceutical sector to keep Medicago's expertise and skilled workforce in Quebec. He said both the Quebec and federal governments would be willing to put in money to secure a deal.
“We can't operate it ourselves; the government will not be the main shareholder,” Fitzgibbon said. “But if there is a pharmaceutical company that considers it's worth continuing, we're ready to help.”
Mitsubishi Chemical said Thursday it would stop marketing the Medicago-produced Covifenz vaccine, which is plant-based and was approved by Health Canada one year ago for adults aged 18 to 64.
The Japanese chemical company said it had been preparing to commercially produce the Covifenz vaccine, but decided against doing so because of the “significant changes” in the COVID -19 vaccine environment. The company said it would dissolve Medicago because it is no longer “viable” to continue marketing its products.
“In light of significant changes to the COVID-19 vaccine landscape since the approval of Covifenz, and after a comprehensive review of the current global demand and market environment for COVID-19 vaccines and Medicago's challenges in transitioning to commercial-scale production, the (company) has determined that it will not pursue the commercialization of Covifenz,” Mitsubishi Chemical said in a statement.
Canada invested $173 million in Medicago in 2020.
In a statement, a spokesperson for Innovation, Science and Industry Minister Francois-philippe Champagne said talks with Quebec about next steps are ongoing.
“Medicago's contribution to Canada's biomanufacturing and life sciences ecosystem is important because of their innovative plant-based vaccine technology,” Laurie Bouchard said.